Literature DB >> 20957626

Regulation of tissue- and stimulus-specific cell fate decisions by p53 in vivo.

James G Jackson1, Sean M Post, Guillermina Lozano.   

Abstract

The tumour suppressor p53 pathway is often inactivated by multiple mechanisms in the genesis of human cancers. Aberrant cellular proliferation, DNA damage, hypoxia, and ribosomal stress cause activation of the p53 tumour suppressor with multiple possible consequences to the cell: cell death, cell cycle arrest, or senescence. These mechanisms ultimately ensure that the cell does not replicate, and are thus potent tumour suppressor mechanisms. An important question that has eluded the field is how p53 makes these cell fate decisions. This review summarizes the current status of knowledge regarding p53-mediated stress and tissue-dependent cell fate decisions in mouse models and human tumours.
Copyright © 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20957626     DOI: 10.1002/path.2783

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  32 in total

1.  Using targeted transgenic reporter mice to study promoter-specific p53 transcriptional activity.

Authors:  Amanda M Goh; Chin Yan Lim; Poh Cheang Chiam; Ling Li; Michael B Mann; Karen M Mann; Sergio Menendez; David P Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

2.  Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes.

Authors:  Che-Pei Kung; Sakina Khaku; Matthew Jennis; Yan Zhou; Maureen E Murphy
Journal:  Mol Cancer Res       Date:  2014-09-25       Impact factor: 5.852

3.  Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses.

Authors:  Steven Pennock; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

4.  p53 drives a transcriptional program that elicits a non-cell-autonomous response and alters cell state in vivo.

Authors:  Sydney M Moyer; Amanda R Wasylishen; Yuan Qi; Natalie Fowlkes; Xiaoping Su; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-08       Impact factor: 11.205

5.  Wild-type tumor repressor protein 53 (Trp53) promotes ovarian cancer cell survival.

Authors:  Lisa K Mullany; Zhilin Liu; Erin R King; Kwong-Kwok Wong; JoAnne S Richards
Journal:  Endocrinology       Date:  2012-03-06       Impact factor: 4.736

Review 6.  Minireview: animal models and mechanisms of ovarian cancer development.

Authors:  Lisa K Mullany; JoAnne S Richards
Journal:  Endocrinology       Date:  2012-03-06       Impact factor: 4.736

7.  Tissue-specific and age-dependent effects of global Mdm2 loss.

Authors:  Yun Zhang; Shunbin Xiong; Qin Li; Sophia Hu; Mehrnoosh Tashakori; Carolyn Van Pelt; Mingjian James You; Laura Pageon; Guillermina Lozano
Journal:  J Pathol       Date:  2014-06-09       Impact factor: 7.996

8.  Global re-wiring of p53 transcription regulation by the hepatitis B virus X protein.

Authors:  Cheryl Chan; Thomas Thurnherr; Jingbo Wang; Xavier Gallart-Palau; Siu Kwan Sze; Steve Rozen; Caroline G Lee
Journal:  Mol Oncol       Date:  2016-06-02       Impact factor: 6.603

9.  Low-dose radiation exposure induces a HIF-1-mediated adaptive and protective metabolic response.

Authors:  R Lall; S Ganapathy; M Yang; S Xiao; T Xu; H Su; M Shadfan; J M Asara; C S Ha; I Ben-Sahra; B D Manning; J B Little; Z-M Yuan
Journal:  Cell Death Differ       Date:  2014-02-28       Impact factor: 15.828

Review 10.  Another fork in the road--life or death decisions by the tumour suppressor p53.

Authors:  Luis A Carvajal; James J Manfredi
Journal:  EMBO Rep       Date:  2013-04-16       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.